GSK2140944 Gepotidacin
- 公司名稱 MedChemExpress LLC
- 品牌 MedChemExpress (MCE)
- 型號 GSK2140944
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2019/6/27 11:24:57
- 訪問次數(shù) 613
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
MedChemExpress (MCE) 專注于為科學(xué)家提供高品質(zhì)的生物活性小分子化合物，化合物庫及各類試劑盒，總部位于美國新澤西。
• MedChemExpress (MCE) 產(chǎn)品作用于 20 多個熱門信號通路及研究領(lǐng)域的300多個細分靶點，擁有 10000 特異性抑制劑、激動劑，以及 50 活性化合物篩選庫；
• 我們堅持對所有產(chǎn)品進行嚴格質(zhì)檢，確保產(chǎn)品的高品質(zhì)和高純度；
• MedChemExpress (MCE) 產(chǎn)品已被數(shù)萬名科學(xué)家信賴，并被大量top文獻和*引用；
• 我們擁有專業(yè)的技術(shù)團隊追蹤前沿科研進展，不斷豐富各個靶點的特異性產(chǎn)品，堅持做 “您身邊的抑制劑大師”；
• MedChemExpress (MCE) 與眾多藥企和科研機構(gòu)保持深度合作；
• 大量產(chǎn)品有中國庫存，工作日 16:00 前訂單確保當(dāng)日發(fā)貨，次日送達。
MCE 中國站：www.MedChemExpress.cn
Hotline: 400-820-3792
Tel: 021-58955995
Email: sales@MedChemExpress.cn
Tech Support: 021-58950656
抑制劑，調(diào)節(jié)劑，API，天然產(chǎn)物，各種類型化合物庫
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL；1 mg；5 mg |
|---|---|---|---|
| 貨號 | HY-16742 | 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè) |
Gepotidacin
產(chǎn)品活性：Gepotidacin (GSK2140944)是一種新型的三氮雜苊烯細菌II型拓撲異構(gòu)酶抑制劑。
研究領(lǐng)域：Anti-infection
作用靶點：Bacterial
In Vitro: Gepotidacin is a novel, first-in-class, triazaacenaphthylene antibacterial that inhibits bacterial DNA gyrase and topoisomerase IV via a unique mechanism and has demonstrated in vitro activity against gram-negative and gram-positive bacterias , including drug-resistant strains, and also targets pathogens associated with other conventional and biothreat infections. The MIC50 and MIC90 for gepotidacin against the 25 N. gonorrhoeae isolates tested are 0.12 and 0.25 μg/mL, respectively. The gepotidacin MIC90s are as follows (in μg/mL): Streptococcus pyogenes, 0.25; Escherichia coli, 2; Moraxella catarrhalis, ≤0.06; Streptococcus pneumoniae, 0.25; Haemophilus influenzae, 1; Clostridium perfringens, 0.5; and Shigella spp., 1. Gepotidacin hasin vitroactivity against causative pathogens of acute bacterial skin and skin structure infections (ABSSSIs).
In Vivo: GSK2140944 MICs are 0.125 to 0.5 mg/L against the six MRSA isolates. ELF penetration ratios range from 1.1 to 1.4. Observed maximal decreases are 1.1 to 3.1 log10 CFU in neutropenic mice. The mean fAUC/MIC ratios required for stasis and 1-log-unit decreases are 59.3 ± 34.6 and 148.4 ± 83.3, respectively.
相關(guān)產(chǎn)品：Drug Repurposing Compound Library | Anti-Infection Compound Library | Clinical Compound Library | Clinical Compound Library Plus | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Puromycin Dihydrochloride | Tunicamycin | G-418 disulfate | Hygromycin B | Bleomycin sulfate | Vancomycin hydrochloride | Ampicillin sodium | Neomycin sulfate | Salinomycin | Avibactam sodium | Vaborbactam | Rifampicin | Minocycline hydrochloride | Bedaquiline | Carbenicillin disodium | Ciprofloxacin | Gentamicin sulfate | Metronidazole | Kanamycin sulfate | Methicillin sodium salt | Eravacycline dihydrochloride | Ceftazidime | Berberine chloride hydrate | Rimonabant Hydrochloride | Omadacycline hydrochloride | Chloramphenicol | Puromycin aminonucleoside | Tetracycline hydrochloride | Cefotaxime sodium salt
采購中心
化工儀器網(wǎng)